genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke缺genetically-defined mannose-binding凝集素与保护实验中风后在小鼠和人类中风的结果.pdfVIP

下载本文档

1
0
约6.78万字
约 10页
2017-09-01 发布于上海
举报
版权申诉

genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke缺genetically-defined mannose-binding凝集素与保护实验中风后在小鼠和人类中风的结果.pdf

1、有哪些信誉好的足球投注网站（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke缺genetically-defined mannose-binding凝集素与保护实验中风后在小鼠和人类中风的结果

Genetically-Defined Deficiency of Mannose-Binding Lectin Is Associated with Protection after Experimental Stroke in Mice and Outcome in Human Stroke 1 2 2 1 3 4,5 Alvaro Cervera , Anna M. Planas , Carles Justicia , Xabier Urra , Jens C. Jensenius , Ferran Torres , 5,6 1 Francisco Lozano *, Angel Chamorro * ´ ` 1 Comprehensive Stroke Center, Hospital Clınic, Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Medical School, University of Barcelona, Barcelona, ` ´ Spain, 2 Department of Brain Ischemia and Neurodegeneration, Institut d’Investigacions Biomediques de Barcelona (IIBB)-Consejo Superior de Investigaciones Cientıficas ` (CSIC), Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, 3 Department of Medical Microbiology and Immunology, University of Aarhus, ´ ` Aarhus, Denmark, 4 Clinical Pharmacology Unit, Hospital Clınic, Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Medical School, University of Barcelona, Barcelona, Spain, 5 Department of Cellular Biology, Immunology, and Neuroscience, Medical School, University of Barcelona, Barcelona, Spain, 6 Immunology Department, ´ ` Hospital Clınic, Institut d’Investigacions Biomediques August Pi i Su